U.S. Medical Equipment Stock News

NYSE:MOV
NYSE:MOVLuxury

Movado Group (MOV) Margin Gain And 80.4% TTM Earnings Growth Test Bullish Narratives

Movado Group (MOV) just posted Q1 2027 results with revenue of US$142.4 million and basic EPS of US$0.30, compared with trailing twelve month revenue of US$681.9 million and EPS of US$1.44 that delivered year-over-year earnings growth of 80.4%. Over the last year, revenue has been broadly steady at 0.4% growth while net profit margin moved from 2.7% to 4.7%. This sets up this quarter as part of a wider shift in the earnings profile. For investors, that margin progression, combined with the...
NYSE:ANF
NYSE:ANFSpecialty Retail

Abercrombie & Fitch (ANF) Margin Decline Tests Bullish Profitability Narratives In Q1 2027

Abercrombie & Fitch (ANF) opened Q1 2027 with revenue of US$1.1b and basic EPS of US$1.49, alongside net income of US$67.1m for the quarter. The company recorded quarterly revenue of US$1.10b in Q1 2026 and US$1.11b in Q1 2027, while basic EPS moved from US$1.63 to US$1.49 over the same period. This presents a picture in which investors are weighing solid top line scale against more mixed per share outcomes. With trailing net margin coming in lower than the prior year in the provided data,...
NYSE:JBL
NYSE:JBLElectronic

Jabil (JBL) Is Up 7.6% After Yield‑Driven Risk Rally Lifted Cyclicals Has The Bull Case Changed?

Earlier this week, Jabil was part of a broader move in U.S. equities as easing Treasury yields and progress on Iran‑US peace discussions lifted corporate confidence and demand for cyclically exposed manufacturers. This macro‑driven sentiment shift comes shortly after concerns about Jabil’s valuation and recent insider share sales, highlighting a tension between optimism and perceived risk. Next, we’ll examine how improving risk appetite tied to lower Treasury yields may influence Jabil’s...
NYSE:WFC
NYSE:WFCBanks

Is It Too Late To Consider Wells Fargo (WFC) After A 20% Year To Date Decline?

Wondering if Wells Fargo at around US$76 per share still offers value, or if most of the opportunity has already been priced in? This article breaks that question down using several valuation tools. The stock is close to its recent last close of US$76.11, with a modest 0.4% gain over the past week but a decline of 5.5% over the past month and a larger fall of 20.1% year to date, set against a 5.5% return over the last year and 106.0% over three years. Recent coverage has focused on Wells...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) Turns Q1 EPS Profit Into Test Of Ongoing Turnaround Narratives

Semtech (SMTC) opened Q1 2027 with revenue of about US$291 million, basic EPS of roughly US$0.29 and net income of around US$26.6 million, providing a clear snapshot of its latest quarterly performance. The company reported revenue of about US$251.1 million in Q1 2026 and roughly US$291 million in Q1 2027, while basic EPS moved from about US$0.22 to roughly US$0.29 over the same period. This offers investors a direct view of how the top and bottom line compare year on year. Overall, margins...
NYSE:ATEN
NYSE:ATENSoftware

A Fresh Look At A10 Networks (ATEN) Valuation After Strong Recent Share Price Performance

Stock move and recent performance context A10 Networks (ATEN) has recently attracted investor attention after its share price movement, prompting a closer look at how the stock has been trading over the past month and past 3 months. See our latest analysis for A10 Networks. A10 Networks' recent momentum has been strong, with a 30 day share price return of 5.27% and a 90 day share price return of 51.35%. The 1 year total shareholder return of 72.12% and 5 year total shareholder return of 221%...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

A Look At Walmart (WMT) Valuation After Solid Results And Cautious Outlook On Costs

Walmart (WMT) is back in focus after solid first quarter results, with revenue of US$177.8b and net income of US$5.3b, followed by cautious guidance that coincided with a sharp pullback in the stock. See our latest analysis for Walmart. That cautious first quarter outlook and worries about fuel costs have hit sentiment hard, with the share price down 9.4% over the past week and 7.1% over the past month, even though the 1 year total shareholder return is 22.9% and the 5 year total shareholder...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

A Look At Zoom Communications (ZM) Valuation After Its Corporate Rebrand And AI Platform Focus

Zoom Communications (ZM) recently completed its corporate rebrand from Zoom Video Communications, signaling a broader focus on its AI first open work platform and multi product ecosystem beyond core video meetings. See our latest analysis for Zoom Communications. At a share price of US$99.96, Zoom’s recent momentum has picked up, with a 30 day share price return of 10.05% and a 90 day gain of 32.33%. The 1 year total shareholder return of 25.47% contrasts with a 5 year total shareholder...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Assessing Berkshire Hathaway (BRK.A) Valuation After Recent Flat Performance And Mixed Momentum

Event overview and recent share performance Berkshire Hathaway (BRK.A) is back in focus after recent trading left the stock down slightly over the past week and roughly flat over the past month, prompting investors to reassess its long term role in portfolios. See our latest analysis for Berkshire Hathaway. Stepping back, Berkshire Hathaway’s share price return is down 3.4% year to date and down 4.6% over the past 90 days, while its 3 year total shareholder return of 47.3% points to stronger...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Evaluating Fulton Financial (FULT) After Recent Mixed Returns And Modest Undervaluation Claims

Fulton Financial (FULT) has drawn investor attention after recent share price moves, with the stock closing at US$21.60. Short term returns have been mixed, while longer term performance remains meaningfully positive. See our latest analysis for Fulton Financial. Recent trading has been relatively muted, with the share price slipping 0.8% over the last day and 1.5% over the past month. The year to date share price return of 10.9% sits alongside a 1 year total shareholder return of 30.3%,...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Is It Too Late To Consider Qualcomm (QCOM) After Its Recent Share Price Surge?

If you are wondering whether QUALCOMM at US$233.40 still offers value or if you may be arriving late to the story, this article breaks down what the current price may imply. The stock has posted returns of 15.3% over the past 7 days, 55.3% over 30 days, 34.9% year to date, 61.8% over 1 year, 118.8% over 3 years and 93.6% over 5 years, which is likely to influence how investors think about both upside and risk. Recent coverage has focused on QUALCOMM's position in semiconductors and wireless...
NYSE:LAZ
NYSE:LAZCapital Markets

Assessing Lazard (LAZ) Valuation After Soft Q1 Results And Campbell Lutyens Acquisition

What Lazard’s board changes mean for shareholders Lazard (LAZ) is moving from a staggered, multi year board structure to annual director elections. This governance shift could change how quickly shareholders influence the company after a mixed start to the year. See our latest analysis for Lazard. The governance change comes after a mixed few months for the stock, with the share price down 9.02% over 90 days and 3.22% year to date. However, the 3 year total shareholder return is 92.91%,...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Why Recursion Pharmaceuticals (RXRX) Is Up 7.1% After Extending Cash Runway And Advancing REC-4881

Earlier in May 2026, Recursion Pharmaceuticals reported first-quarter revenue of US$6.5 million, a reduced net loss, and confirmed that its cash and cash equivalents are expected to support operations into early 2028 while advancing multiple clinical programs, including REC-4881, REC-1245, and REC-4539. A particularly interesting development is the Phase 2 efficacy signal for REC-4881 in familial adenomatous polyposis, which underscores how Recursion’s AI-native discovery platform is...
NYSE:EPD
NYSE:EPDOil and Gas

A Look At Enterprise Products Partners (EPD) Valuation After Strong Long Term Returns And Expansion Plans

Enterprise Products Partners at a glance Enterprise Products Partners (EPD) remains in focus for income oriented investors, with the stock recently closing at $37.99 and the partnership generating revenue of $51.57b and net income of $5.84b. See our latest analysis for Enterprise Products Partners. Recent trading has been a little softer, with the share price down 3.6% over the past week, but the 18.1% year to date share price return and 5 year total shareholder return of 123.9% point to...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Is Astec Industries (ASTE) Fairly Priced After Recent Infrastructure Spending Optimism?

Wondering if Astec Industries at about US$51 per share is offering fair value right now, or if the recent price puts you at risk of overpaying? The stock is up 4.9% over the last 7 days and 14.4% year to date, although it is down 13.1% over the past month, with a 31.0% return over the last year and 44.0% over three years, while the five-year return shows a decline of 20.8%. Recent headlines around infrastructure spending, construction activity and heavy equipment demand have kept attention...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet Recall Puts Omnipod Reliability And Valuation In Investor Focus

Insulet (NasdaqGS:PODD) issued a voluntary recall and medical device correction for certain Omnipod insulin Pods due to a manufacturing defect that can cause insulin under delivery. The action affects roughly 7 million Pods globally across the Omnipod 5, DASH, and Eros product lines. Insulet has received multiple reports of serious adverse events, including at least 24 severe cases requiring hospitalization, but no fatalities. The company is replacing affected Pods at no cost and does not...
NYSE:PWR
NYSE:PWRConstruction

The Bull Case For Quanta Services (PWR) Could Change Following New Buyback, Dividend And Board Appointment

Earlier this month, Quanta Services appointed Joseph Kim to its board, authorized a US$1.00 billion share repurchase program, and affirmed a quarterly dividend of US$0.11 per share payable on July 13, 2026. These moves combine fresh boardroom expertise in supply chain and logistics with capital returns that underscore management’s current priorities around buybacks and steady income. Next, we’ll examine how the new US$1.00 billion buyback authorization could influence Quanta’s existing...
NasdaqCM:CRBP
NasdaqCM:CRBPBiotechs

Corbus Pharmaceuticals (CRBP) Is Down 19.6% After FDA Aligns On CRB-701 Registrational Strategy - Has The Bull Case Changed?

Corbus Pharmaceuticals reported updated Phase 1/2 data for its Nectin-4 antibody‑drug conjugate CRB-701, showing robust activity and manageable safety in HPV‑driven oropharyngeal and cervical cancers, with plans to present the results at the ASCO 2026 meeting and to launch registrational trials in both indications. An interesting development is the FDA’s broad alignment on registrational trial designs targeting accelerated approval in second‑line oropharyngeal squamous cell carcinoma and...
NYSE:AGX
NYSE:AGXConstruction

Argan (AGX) Is Up 6.8% After Q4 Earnings Beat Raised Analyst Forecasts - What's Changed

Earlier this month, Argan Inc. reported fourth-quarter earnings of US$3.47 per share on revenue of US$262.1 million, exceeding Wall Street expectations. The earnings beat has prompted analysts to revisit their assumptions on Argan's earnings power and project execution ahead of its upcoming first-quarter 2026 results on June 4. Next, we'll examine how this earnings outperformance and raised analyst forecasts may reshape Argan's existing investment narrative around backlog and margins. We've...
NYSE:V
NYSE:VDiversified Financial

A Look At Visa (V) Valuation After Recent Share Price Rebound

Why Visa (V) is back on investors’ radar Visa (V) has attracted fresh attention after a recent shift in its share performance, with the stock up about 6% over the past month following earlier year to date and 1 year declines. See our latest analysis for Visa. Visa’s recent 5.8% 30 day share price return contrasts with a year to date decline of 5.45% and a 1 year total shareholder return that is down 8.21%, while the 3 year total shareholder return of 51.64% points to stronger longer term...
NasdaqGS:EA
NasdaqGS:EAEntertainment

Is It Too Late To Consider Electronic Arts (EA) After Its Strong 1 Year Rally?

Wondering if Electronic Arts at around US$200 a share still offers value, or if most of the upside is already priced in. The stock recently closed at US$200.68, with returns that slipped 0.5% over 7 days, 0.9% over 30 days, and 1.8% year to date, while the 1 year return sits at 37.2% and the 3 and 5 year returns are 59.1% and 45.7%. Recent coverage has focused on Electronic Arts as a large player in gaming, with ongoing interest in its major franchises and live services. This helps explain...
NYSE:CPK
NYSE:CPKGas Utilities

Assessing Chesapeake Utilities (CPK) Valuation After Recent Share Price Softness

Chesapeake Utilities overview and recent share performance Chesapeake Utilities (CPK) has drawn investor attention after recent share price moves, with the stock down about 1% over the past month and roughly 6% over the past 3 months. That has prompted closer scrutiny of its fundamentals and valuation. See our latest analysis for Chesapeake Utilities. At the current share price of $125.85, Chesapeake Utilities has seen some recent share price pressure, with the 90 day share price return down...
NYSE:D
NYSE:DIntegrated Utilities

Dominion Energy Faces Landmark All Stock Merger And Valuation Question Marks

NextEra Energy and Dominion Energy (NYSE:D) have announced a definitive all stock agreement. The transaction would create the largest utility company in the U.S. if completed. The combined company is expected to operate with dual headquarters and a shared leadership structure. The deal would broaden reach across key power markets serving data centers and electrification trends. Dominion Energy enters this merger process with its shares at $67.2 and a return of 25.8% over the past year,...
NasdaqGS:MNRO
NasdaqGS:MNROSpecialty Retail

Monro (MNRO) Q4 Loss Revives Concerns Over Reliability Of Recent Profit Turnaround

Monro (MNRO) closed FY 2026 with fourth quarter revenue of US$273.8 million and a reported loss of US$6.6 million, equal to EPS of US$0.22, against a trailing twelve month profit of US$2.2 million and EPS of US$0.07 on revenue of US$1.2 billion. Over recent quarters the company has seen revenue move between US$305.8 million in Q3 FY 2025, US$301.0 million in Q1 FY 2026, US$288.9 million in Q2, US$293.4 million in Q3 and US$273.8 million in Q4. EPS has swung from a loss of US$0.72 in Q4 FY...